Short-course adjuvant trastuzumab in breast cancer: Experience from a tertiary cancer center in rural India

Introduction: Majority of the patients in low-to-middle income countries (LMICs) have no access to adjuvant trastuzumab due to financial constraints. Short-course (9 weeks) schedule of trastuzumab is a feasible alternative in this setting. The objective of this study was to assess the feasibility an...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Avaronnan Manuprasad, Praveen Kumar Shenoy, Joneetha Jones, N V Vinin, Adarsh Dharmarajan, Geetha Muttath
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wolters Kluwer Medknow Publications 2020-01-01
coleção:	Cancer Research, Statistics, and Treatment
Assuntos:	breast cancer india short course trastuzumab lmic her2 brca
Acesso em linha:	http://www.crstonline.com/article.asp?issn=2590-3233;year=2020;volume=3;issue=1;spage=69;epage=73;aulast=Manuprasad
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!